#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0152] In addition, Example 3 shows additional biochemical data which provides evidence that PUFAs in Schizochytrium are not produced by the classical pathway (i.e., precursor product kinetics between C16:0 and DHA are not observed in whole cells and, in vitro PUFA synthesis can be separated from the membrane fraction--all of the fatty acid desaturases of the classical PUFA synthesis pathway, with the exception of the delta 9 desaturase which inserts the first double bond of the series, are associated with cellular membranes).
1-1	0-1	[	_	_	
1-2	1-5	0152	_	_	
1-3	5-6	]	_	_	
1-4	7-9	In	_	_	
1-5	10-18	addition	_	_	
1-6	18-19	,	_	_	
1-7	20-27	Example	_	_	
1-8	28-29	3	_	_	
1-9	30-35	shows	_	_	
1-10	36-46	additional	_	_	
1-11	47-58	biochemical	_	_	
1-12	59-63	data	_	_	
1-13	64-69	which	_	_	
1-14	70-78	provides	_	_	
1-15	79-87	evidence	_	_	
1-16	88-92	that	_	_	
1-17	93-98	PUFAs	_	_	
1-18	99-101	in	_	_	
1-19	102-116	Schizochytrium	_	_	
1-20	117-120	are	_	_	
1-21	121-124	not	_	_	
1-22	125-133	produced	_	_	
1-23	134-136	by	_	_	
1-24	137-140	the	_	_	
1-25	141-150	classical	_	_	
1-26	151-158	pathway	_	_	
1-27	159-160	(	_	_	
1-28	160-163	i.e	_	_	
1-29	163-164	.	_	_	
1-30	164-165	,	_	_	
1-31	166-175	precursor	_	_	
1-32	176-183	product	_	_	
1-33	184-192	kinetics	_	_	
1-34	193-200	between	_	_	
1-35	201-204	C16	_	_	
1-36	204-205	:	_	_	
1-37	205-206	0	_	_	
1-38	207-210	and	_	_	
1-39	211-214	DHA	_	_	
1-40	215-218	are	_	_	
1-41	219-222	not	_	_	
1-42	223-231	observed	_	_	
1-43	232-234	in	_	_	
1-44	235-240	whole	_	_	
1-45	241-246	cells	_	_	
1-46	247-250	and	_	_	
1-47	250-251	,	_	_	
1-48	252-254	in	_	_	
1-49	255-260	vitro	_	_	
1-50	261-265	PUFA	_	_	
1-51	266-275	synthesis	_	_	
1-52	276-279	can	_	_	
1-53	280-282	be	_	_	
1-54	283-292	separated	_	_	
1-55	293-297	from	_	_	
1-56	298-301	the	_	_	
1-57	302-310	membrane	_	_	
1-58	311-319	fraction	_	_	
1-59	319-320	-	_	_	
1-60	320-321	-	_	_	
1-61	321-324	all	_	_	
1-62	325-327	of	_	_	
1-63	328-331	the	_	_	
1-64	332-337	fatty	_	_	
1-65	338-342	acid	_	_	
1-66	343-354	desaturases	_	_	
1-67	355-357	of	_	_	
1-68	358-361	the	_	_	
1-69	362-371	classical	_	_	
1-70	372-376	PUFA	_	_	
1-71	377-386	synthesis	_	_	
1-72	387-394	pathway	_	_	
1-73	394-395	,	_	_	
1-74	396-400	with	_	_	
1-75	401-404	the	_	_	
1-76	405-414	exception	_	_	
1-77	415-417	of	_	_	
1-78	418-421	the	_	_	
1-79	422-427	delta	_	_	
1-80	428-429	9	_	_	
1-81	430-440	desaturase	_	_	
1-82	441-446	which	_	_	
1-83	447-454	inserts	_	_	
1-84	455-458	the	_	_	
1-85	459-464	first	_	_	
1-86	465-471	double	_	_	
1-87	472-476	bond	_	_	
1-88	477-479	of	_	_	
1-89	480-483	the	_	_	
1-90	484-490	series	_	_	
1-91	490-491	,	_	_	
1-92	492-495	are	_	_	
1-93	496-506	associated	_	_	
1-94	507-511	with	_	_	
1-95	512-520	cellular	_	_	
1-96	521-530	membranes	_	_	
1-97	530-531	)	_	_	
1-98	531-532	.	_	_	

#Text=This type of biochemical data could be used to detect PUFA PKS activity in microbe identified by the novel screening method described above.
#Text=[0153] Preferred microbial strains to screen using the screening/identification method of the present invention are chosen from the group consisting of: bacteria, algae, fungi, protozoa or protists, but most preferably from the eukaryotic microbes consisting of algae, fungi, protozoa and protists.
2-1	533-537	This	_	_	
2-2	538-542	type	_	_	
2-3	543-545	of	_	_	
2-4	546-557	biochemical	_	_	
2-5	558-562	data	_	_	
2-6	563-568	could	_	_	
2-7	569-571	be	_	_	
2-8	572-576	used	_	_	
2-9	577-579	to	_	_	
2-10	580-586	detect	_	_	
2-11	587-591	PUFA	_	_	
2-12	592-595	PKS	_	_	
2-13	596-604	activity	_	_	
2-14	605-607	in	_	_	
2-15	608-615	microbe	_	_	
2-16	616-626	identified	_	_	
2-17	627-629	by	_	_	
2-18	630-633	the	_	_	
2-19	634-639	novel	_	_	
2-20	640-649	screening	_	_	
2-21	650-656	method	_	_	
2-22	657-666	described	_	_	
2-23	667-672	above	_	_	
2-24	672-673	.	_	_	
2-25	674-675	[	_	_	
2-26	675-679	0153	_	_	
2-27	679-680	]	_	_	
2-28	681-690	Preferred	_	_	
2-29	691-700	microbial	_	_	
2-30	701-708	strains	_	_	
2-31	709-711	to	_	_	
2-32	712-718	screen	_	_	
2-33	719-724	using	_	_	
2-34	725-728	the	_	_	
2-35	729-738	screening	_	_	
2-36	738-739	/	_	_	
2-37	739-753	identification	_	_	
2-38	754-760	method	_	_	
2-39	761-763	of	_	_	
2-40	764-767	the	_	_	
2-41	768-775	present	_	_	
2-42	776-785	invention	_	_	
2-43	786-789	are	_	_	
2-44	790-796	chosen	_	_	
2-45	797-801	from	_	_	
2-46	802-805	the	_	_	
2-47	806-811	group	_	_	
2-48	812-822	consisting	_	_	
2-49	823-825	of	_	_	
2-50	825-826	:	_	_	
2-51	827-835	bacteria	_	_	
2-52	835-836	,	_	_	
2-53	837-842	algae	_	_	
2-54	842-843	,	_	_	
2-55	844-849	fungi	_	_	
2-56	849-850	,	_	_	
2-57	851-859	protozoa	_	_	
2-58	860-862	or	_	_	
2-59	863-871	protists	_	_	
2-60	871-872	,	_	_	
2-61	873-876	but	_	_	
2-62	877-881	most	_	_	
2-63	882-892	preferably	_	_	
2-64	893-897	from	_	_	
2-65	898-901	the	_	_	
2-66	902-912	eukaryotic	_	_	
2-67	913-921	microbes	_	_	
2-68	922-932	consisting	_	_	
2-69	933-935	of	_	_	
2-70	936-941	algae	_	_	
2-71	941-942	,	_	_	
2-72	943-948	fungi	_	_	
2-73	948-949	,	_	_	
2-74	950-958	protozoa	_	_	
2-75	959-962	and	_	_	
2-76	963-971	protists	_	_	
2-77	971-972	.	_	_	

#Text=These microbes are preferably capable of growth and production of the bioactive compounds containing two or more unsaturated bonds at temperatures greater than about 15.degree.
3-1	973-978	These	_	_	
3-2	979-987	microbes	_	_	
3-3	988-991	are	_	_	
3-4	992-1002	preferably	_	_	
3-5	1003-1010	capable	_	_	
3-6	1011-1013	of	_	_	
3-7	1014-1020	growth	_	_	
3-8	1021-1024	and	_	_	
3-9	1025-1035	production	_	_	
3-10	1036-1038	of	_	_	
3-11	1039-1042	the	_	_	
3-12	1043-1052	bioactive	_	_	
3-13	1053-1062	compounds	_	_	
3-14	1063-1073	containing	_	_	
3-15	1074-1077	two	_	_	
3-16	1078-1080	or	_	_	
3-17	1081-1085	more	_	_	
3-18	1086-1097	unsaturated	_	_	
3-19	1098-1103	bonds	_	_	
3-20	1104-1106	at	_	_	
3-21	1107-1119	temperatures	_	_	
3-22	1120-1127	greater	_	_	
3-23	1128-1132	than	_	_	
3-24	1133-1138	about	_	_	
3-25	1139-1141	15	_	_	
3-26	1141-1142	.	_	_	
3-27	1142-1148	degree	_	_	
3-28	1148-1149	.	_	_	

#Text=C., more preferably greater than about 20.degree.
4-1	1150-1151	C	_	_	
4-2	1151-1152	.	_	_	
4-3	1152-1153	,	_	_	
4-4	1154-1158	more	_	_	
4-5	1159-1169	preferably	_	_	
4-6	1170-1177	greater	_	_	
4-7	1178-1182	than	_	_	
4-8	1183-1188	about	_	_	
4-9	1189-1191	20	_	_	
4-10	1191-1192	.	_	_	
4-11	1192-1198	degree	_	_	
4-12	1198-1199	.	_	_	

#Text=C., even more preferably greater than about 25.degree.
5-1	1200-1201	C	_	_	
5-2	1201-1202	.	_	_	
5-3	1202-1203	,	_	_	
5-4	1204-1208	even	_	_	
5-5	1209-1213	more	_	_	
5-6	1214-1224	preferably	_	_	
5-7	1225-1232	greater	_	_	
5-8	1233-1237	than	_	_	
5-9	1238-1243	about	_	_	
5-10	1244-1246	25	_	_	
5-11	1246-1247	.	_	_	
5-12	1247-1253	degree	_	_	
5-13	1253-1254	.	_	_	

#Text=C. and most preferably greater than about 30.degree.
6-1	1255-1256	C	_	_	
6-2	1256-1257	.	_	_	
6-3	1258-1261	and	_	_	
6-4	1262-1266	most	_	_	
6-5	1267-1277	preferably	_	_	
6-6	1278-1285	greater	_	_	
6-7	1286-1290	than	_	_	
6-8	1291-1296	about	_	_	
6-9	1297-1299	30	_	_	
6-10	1299-1300	.	_	_	
6-11	1300-1306	degree	_	_	
6-12	1306-1307	.	_	_	

#Text=C.
#Text=[0154] In some embodiments of this method of the present invention, novel bacterial PUFA PKS systems can be identified in bacteria that produce PUFAs at temperatures exceeding about 20.degree.
7-1	1308-1309	C	_	_	
7-2	1309-1310	.	_	_	
7-3	1311-1312	[	_	_	
7-4	1312-1316	0154	_	_	
7-5	1316-1317	]	_	_	
7-6	1318-1320	In	_	_	
7-7	1321-1325	some	_	_	
7-8	1326-1337	embodiments	_	_	
7-9	1338-1340	of	_	_	
7-10	1341-1345	this	_	_	
7-11	1346-1352	method	_	_	
7-12	1353-1355	of	_	_	
7-13	1356-1359	the	_	_	
7-14	1360-1367	present	_	_	
7-15	1368-1377	invention	_	_	
7-16	1377-1378	,	_	_	
7-17	1379-1384	novel	_	_	
7-18	1385-1394	bacterial	_	_	
7-19	1395-1399	PUFA	_	_	
7-20	1400-1403	PKS	_	_	
7-21	1404-1411	systems	_	_	
7-22	1412-1415	can	_	_	
7-23	1416-1418	be	_	_	
7-24	1419-1429	identified	_	_	
7-25	1430-1432	in	_	_	
7-26	1433-1441	bacteria	_	_	
7-27	1442-1446	that	_	_	
7-28	1447-1454	produce	_	_	
7-29	1455-1460	PUFAs	_	_	
7-30	1461-1463	at	_	_	
7-31	1464-1476	temperatures	_	_	
7-32	1477-1486	exceeding	_	_	
7-33	1487-1492	about	_	_	
7-34	1493-1495	20	_	_	
7-35	1495-1496	.	_	_	
7-36	1496-1502	degree	_	_	
7-37	1502-1503	.	_	_	

#Text=C. preferably exceeding about 25.degree.
8-1	1504-1505	C	_	_	
8-2	1505-1506	.	_	_	
8-3	1507-1517	preferably	_	_	
8-4	1518-1527	exceeding	_	_	
8-5	1528-1533	about	_	_	
8-6	1534-1536	25	_	_	
8-7	1536-1537	.	_	_	
8-8	1537-1543	degree	_	_	
8-9	1543-1544	.	_	_	

#Text=C. and even more preferably exceeding about 30.degree.
9-1	1545-1546	C	_	_	
9-2	1546-1547	.	_	_	
9-3	1548-1551	and	_	_	
9-4	1552-1556	even	_	_	
9-5	1557-1561	more	_	_	
9-6	1562-1572	preferably	_	_	
9-7	1573-1582	exceeding	_	_	
9-8	1583-1588	about	_	_	
9-9	1589-1591	30	_	_	
9-10	1591-1592	.	_	_	
9-11	1592-1598	degree	_	_	
9-12	1598-1599	.	_	_	

#Text=C.
10-1	1600-1601	C	_	_	
10-2	1601-1602	.	_	_	

#Text=As described previously herein, the marine bacteria, Shewanella and Vibrio marinus, described in U.S.
11-1	1603-1605	As	_	_	
11-2	1606-1615	described	_	_	
11-3	1616-1626	previously	_	_	
11-4	1627-1633	herein	_	_	
11-5	1633-1634	,	_	_	
11-6	1635-1638	the	_	_	
11-7	1639-1645	marine	_	_	
11-8	1646-1654	bacteria	_	_	
11-9	1654-1655	,	_	_	
11-10	1656-1666	Shewanella	_	_	
11-11	1667-1670	and	_	_	
11-12	1671-1677	Vibrio	_	_	
11-13	1678-1685	marinus	_	_	
11-14	1685-1686	,	_	_	
11-15	1687-1696	described	_	_	
11-16	1697-1699	in	_	_	
11-17	1700-1703	U.S	_	_	
11-18	1703-1704	.	_	_	

#Text=Pat.
12-1	1705-1708	Pat	_	_	
12-2	1708-1709	.	_	_	

#Text=No. 6,140,486, do not produce PUFAs at higher temperatures, which limits the usefulness of PUFA PKS systems derived from these bacteria, particularly in plant applications under field conditions.
13-1	1710-1712	No	_	_	
13-2	1712-1713	.	_	_	
13-3	1714-1723	6,140,486	_	_	
13-4	1723-1724	,	_	_	
13-5	1725-1727	do	_	_	
13-6	1728-1731	not	_	_	
13-7	1732-1739	produce	_	_	
13-8	1740-1745	PUFAs	_	_	
13-9	1746-1748	at	_	_	
13-10	1749-1755	higher	_	_	
13-11	1756-1768	temperatures	_	_	
13-12	1768-1769	,	_	_	
13-13	1770-1775	which	_	_	
13-14	1776-1782	limits	_	_	
13-15	1783-1786	the	_	_	
13-16	1787-1797	usefulness	_	_	
13-17	1798-1800	of	_	_	
13-18	1801-1805	PUFA	_	_	
13-19	1806-1809	PKS	_	_	
13-20	1810-1817	systems	_	_	
13-21	1818-1825	derived	_	_	
13-22	1826-1830	from	_	_	
13-23	1831-1836	these	_	_	
13-24	1837-1845	bacteria	_	_	
13-25	1845-1846	,	_	_	
13-26	1847-1859	particularly	_	_	
13-27	1860-1862	in	_	_	
13-28	1863-1868	plant	_	_	
13-29	1869-1881	applications	_	_	
13-30	1882-1887	under	_	_	
13-31	1888-1893	field	_	_	
13-32	1894-1904	conditions	_	_	
13-33	1904-1905	.	_	_	

#Text=Therefore, in one embodiment, the screening method of the present invention can be used to identify bacteria that have a PUFA PKS system which are capable of growth and PUFA production at higher temperatures (e.g., above about 20,25, or 30.degree.
14-1	1906-1915	Therefore	_	_	
14-2	1915-1916	,	_	_	
14-3	1917-1919	in	_	_	
14-4	1920-1923	one	_	_	
14-5	1924-1934	embodiment	_	_	
14-6	1934-1935	,	_	_	
14-7	1936-1939	the	_	_	
14-8	1940-1949	screening	_	_	
14-9	1950-1956	method	_	_	
14-10	1957-1959	of	_	_	
14-11	1960-1963	the	_	_	
14-12	1964-1971	present	_	_	
14-13	1972-1981	invention	_	_	
14-14	1982-1985	can	_	_	
14-15	1986-1988	be	_	_	
14-16	1989-1993	used	_	_	
14-17	1994-1996	to	_	_	
14-18	1997-2005	identify	_	_	
14-19	2006-2014	bacteria	_	_	
14-20	2015-2019	that	_	_	
14-21	2020-2024	have	_	_	
14-22	2025-2026	a	_	_	
14-23	2027-2031	PUFA	_	_	
14-24	2032-2035	PKS	_	_	
14-25	2036-2042	system	_	_	
14-26	2043-2048	which	_	_	
14-27	2049-2052	are	_	_	
14-28	2053-2060	capable	_	_	
14-29	2061-2063	of	_	_	
14-30	2064-2070	growth	_	_	
14-31	2071-2074	and	_	_	
14-32	2075-2079	PUFA	_	_	
14-33	2080-2090	production	_	_	
14-34	2091-2093	at	_	_	
14-35	2094-2100	higher	_	_	
14-36	2101-2113	temperatures	_	_	
14-37	2114-2115	(	_	_	
14-38	2115-2118	e.g	_	_	
14-39	2118-2119	.	_	_	
14-40	2119-2120	,	_	_	
14-41	2121-2126	above	_	_	
14-42	2127-2132	about	_	_	
14-43	2133-2138	20,25	_	_	
14-44	2138-2139	,	_	_	
14-45	2140-2142	or	_	_	
14-46	2143-2145	30	_	_	
14-47	2145-2146	.	_	_	
14-48	2146-2152	degree	_	_	
14-49	2152-2153	.	_	_	

#Text=C.).
15-1	2154-2155	C	_	_	
15-2	2155-2156	.	_	_	
15-3	2156-2157	)	_	_	
15-4	2157-2158	.	_	_	

#Text=In this embodiment, inhibitors of eukaryotic growth such as nystatin (antifungal) or cycloheximide (inhibitor of eukaryotic protein synthesis) can be added to agar plates used to culture/select initial strains from water samples/soil samples collected from the types of habitats/niches described below.
16-1	2159-2161	In	*[1]	17-1[2_1]	
16-2	2162-2166	this	*[1]	_	
16-3	2167-2177	embodiment	*[1]	_	
16-4	2177-2178	,	*[1]	_	
16-5	2179-2189	inhibitors	*[1]	_	
16-6	2190-2192	of	*[1]	_	
16-7	2193-2203	eukaryotic	*[1]	_	
16-8	2204-2210	growth	*[1]	_	
16-9	2211-2215	such	*[1]	_	
16-10	2216-2218	as	*[1]	_	
16-11	2219-2227	nystatin	*[1]	_	
16-12	2228-2229	(	*[1]	_	
16-13	2229-2239	antifungal	*[1]	_	
16-14	2239-2240	)	*[1]	_	
16-15	2241-2243	or	*[1]	_	
16-16	2244-2257	cycloheximide	*[1]	_	
16-17	2258-2259	(	*[1]	_	
16-18	2259-2268	inhibitor	*[1]	_	
16-19	2269-2271	of	*[1]	_	
16-20	2272-2282	eukaryotic	*[1]	_	
16-21	2283-2290	protein	*[1]	_	
16-22	2291-2300	synthesis	*[1]	_	
16-23	2300-2301	)	*[1]	_	
16-24	2302-2305	can	*[1]	_	
16-25	2306-2308	be	*[1]	_	
16-26	2309-2314	added	*[1]	_	
16-27	2315-2317	to	*[1]	_	
16-28	2318-2322	agar	*[1]	_	
16-29	2323-2329	plates	*[1]	_	
16-30	2330-2334	used	*[1]	_	
16-31	2335-2337	to	*[1]	_	
16-32	2338-2345	culture	*[1]	_	
16-33	2345-2346	/	*[1]	_	
16-34	2346-2352	select	*[1]	_	
16-35	2353-2360	initial	*[1]	_	
16-36	2361-2368	strains	*[1]	_	
16-37	2369-2373	from	*[1]	_	
16-38	2374-2379	water	*[1]	_	
16-39	2380-2387	samples	*[1]	_	
16-40	2387-2388	/	*[1]	_	
16-41	2388-2392	soil	*[1]	_	
16-42	2393-2400	samples	*[1]	_	
16-43	2401-2410	collected	*[1]	_	
16-44	2411-2415	from	*[1]	_	
16-45	2416-2419	the	*[1]	_	
16-46	2420-2425	types	*[1]	_	
16-47	2426-2428	of	*[1]	_	
16-48	2429-2437	habitats	*[1]	_	
16-49	2437-2438	/	*[1]	_	
16-50	2438-2444	niches	*[1]	_	
16-51	2445-2454	described	*[1]	_	
16-52	2455-2460	below	*[1]	_	
16-53	2460-2461	.	*[1]	_	

#Text=This process would help select for enrichment of bacterial strains without (or minimal) contamination of eukaryotic strains.
17-1	2462-2466	This	*[2]	_	
17-2	2467-2474	process	*[2]	_	
17-3	2475-2480	would	_	_	
17-4	2481-2485	help	_	_	
17-5	2486-2492	select	_	_	
17-6	2493-2496	for	_	_	
17-7	2497-2507	enrichment	_	_	
17-8	2508-2510	of	_	_	
17-9	2511-2520	bacterial	_	_	
17-10	2521-2528	strains	_	_	
17-11	2529-2536	without	_	_	
17-12	2537-2538	(	_	_	
17-13	2538-2540	or	_	_	
17-14	2541-2548	minimal	_	_	
17-15	2548-2549	)	_	_	
17-16	2550-2563	contamination	_	_	
17-17	2564-2566	of	_	_	
17-18	2567-2577	eukaryotic	_	_	
17-19	2578-2585	strains	_	_	
17-20	2585-2586	.	_	_	

#Text=This selection process, in combination with culturing the plates at elevated temperatures (e.g. 30.degree.
18-1	2587-2591	This	_	_	
18-2	2592-2601	selection	_	_	
18-3	2602-2609	process	_	_	
18-4	2609-2610	,	_	_	
18-5	2611-2613	in	_	_	
18-6	2614-2625	combination	_	_	
18-7	2626-2630	with	_	_	
18-8	2631-2640	culturing	_	_	
18-9	2641-2644	the	_	_	
18-10	2645-2651	plates	_	_	
18-11	2652-2654	at	_	_	
18-12	2655-2663	elevated	_	_	
18-13	2664-2676	temperatures	_	_	
18-14	2677-2678	(	_	_	
18-15	2678-2681	e.g	_	_	
18-16	2681-2682	.	_	_	
18-17	2683-2685	30	_	_	
18-18	2685-2686	.	_	_	
18-19	2686-2692	degree	_	_	
18-20	2692-2693	.	_	_	

#Text=C.), and then selecting strains that produce at least one PUFA would initially identify candidate bacterial strains with a PUFA PKS system that is operative at elevated temperatures (as opposed to those bacterial strains in the prior art which only exhibit PUFA production at temperatures less than about 20.degree.
19-1	2694-2695	C	_	_	
19-2	2695-2696	.	_	_	
19-3	2696-2697	)	_	_	
19-4	2697-2698	,	_	_	
19-5	2699-2702	and	_	_	
19-6	2703-2707	then	_	_	
19-7	2708-2717	selecting	_	_	
19-8	2718-2725	strains	_	_	
19-9	2726-2730	that	_	_	
19-10	2731-2738	produce	_	_	
19-11	2739-2741	at	_	_	
19-12	2742-2747	least	_	_	
19-13	2748-2751	one	_	_	
19-14	2752-2756	PUFA	_	_	
19-15	2757-2762	would	_	_	
19-16	2763-2772	initially	_	_	
19-17	2773-2781	identify	_	_	
19-18	2782-2791	candidate	_	_	
19-19	2792-2801	bacterial	_	_	
19-20	2802-2809	strains	_	_	
19-21	2810-2814	with	_	_	
19-22	2815-2816	a	_	_	
19-23	2817-2821	PUFA	_	_	
19-24	2822-2825	PKS	_	_	
19-25	2826-2832	system	_	_	
19-26	2833-2837	that	_	_	
19-27	2838-2840	is	_	_	
19-28	2841-2850	operative	_	_	
19-29	2851-2853	at	_	_	
19-30	2854-2862	elevated	_	_	
19-31	2863-2875	temperatures	_	_	
19-32	2876-2877	(	_	_	
19-33	2877-2879	as	_	_	
19-34	2880-2887	opposed	_	_	
19-35	2888-2890	to	_	_	
19-36	2891-2896	those	_	_	
19-37	2897-2906	bacterial	_	_	
19-38	2907-2914	strains	_	_	
19-39	2915-2917	in	_	_	
19-40	2918-2921	the	_	_	
19-41	2922-2927	prior	_	_	
19-42	2928-2931	art	_	_	
19-43	2932-2937	which	_	_	
19-44	2938-2942	only	_	_	
19-45	2943-2950	exhibit	_	_	
19-46	2951-2955	PUFA	_	_	
19-47	2956-2966	production	_	_	
19-48	2967-2969	at	_	_	
19-49	2970-2982	temperatures	_	_	
19-50	2983-2987	less	_	_	
19-51	2988-2992	than	_	_	
19-52	2993-2998	about	_	_	
19-53	2999-3001	20	_	_	
19-54	3001-3002	.	_	_	
19-55	3002-3008	degree	_	_	
19-56	3008-3009	.	_	_	

#Text=C. and more preferably below about 5.degree.
20-1	3010-3011	C	_	_	
20-2	3011-3012	.	_	_	
20-3	3013-3016	and	_	_	
20-4	3017-3021	more	_	_	
20-5	3022-3032	preferably	_	_	
20-6	3033-3038	below	_	_	
20-7	3039-3044	about	_	_	
20-8	3045-3046	5	_	_	
20-9	3046-3047	.	_	_	
20-10	3047-3053	degree	_	_	
20-11	3053-3054	.	_	_	

#Text=C.).
#Text=[0155] Locations for collection of the preferred types of microbes for screening for a PUFA PKS system according to the present invention include any of the following: low oxygen environments (or locations near these types of low oxygen environments including in the guts of animals including invertebrates that consume microbes or microbe-containing foods (including types of filter feeding organisms), low or non-oxygen containing aquatic habitats (including freshwater, saline and marine), and especially at-or near-low oxygen environments (regions) in the oceans.
21-1	3055-3056	C	_	_	
21-2	3056-3057	.	_	_	
21-3	3057-3058	)	_	_	
21-4	3058-3059	.	_	_	
21-5	3060-3061	[	_	_	
21-6	3061-3065	0155	_	_	
21-7	3065-3066	]	_	_	
21-8	3067-3076	Locations	_	_	
21-9	3077-3080	for	_	_	
21-10	3081-3091	collection	_	_	
21-11	3092-3094	of	_	_	
21-12	3095-3098	the	_	_	
21-13	3099-3108	preferred	_	_	
21-14	3109-3114	types	_	_	
21-15	3115-3117	of	_	_	
21-16	3118-3126	microbes	_	_	
21-17	3127-3130	for	_	_	
21-18	3131-3140	screening	_	_	
21-19	3141-3144	for	_	_	
21-20	3145-3146	a	_	_	
21-21	3147-3151	PUFA	_	_	
21-22	3152-3155	PKS	_	_	
21-23	3156-3162	system	_	_	
21-24	3163-3172	according	_	_	
21-25	3173-3175	to	_	_	
21-26	3176-3179	the	_	_	
21-27	3180-3187	present	_	_	
21-28	3188-3197	invention	_	_	
21-29	3198-3205	include	_	_	
21-30	3206-3209	any	_	_	
21-31	3210-3212	of	_	_	
21-32	3213-3216	the	_	_	
21-33	3217-3226	following	_	_	
21-34	3226-3227	:	_	_	
21-35	3228-3231	low	_	_	
21-36	3232-3238	oxygen	_	_	
21-37	3239-3251	environments	_	_	
21-38	3252-3253	(	_	_	
21-39	3253-3255	or	_	_	
21-40	3256-3265	locations	_	_	
21-41	3266-3270	near	_	_	
21-42	3271-3276	these	_	_	
21-43	3277-3282	types	_	_	
21-44	3283-3285	of	_	_	
21-45	3286-3289	low	_	_	
21-46	3290-3296	oxygen	_	_	
21-47	3297-3309	environments	_	_	
21-48	3310-3319	including	_	_	
21-49	3320-3322	in	_	_	
21-50	3323-3326	the	_	_	
21-51	3327-3331	guts	_	_	
21-52	3332-3334	of	_	_	
21-53	3335-3342	animals	_	_	
21-54	3343-3352	including	_	_	
21-55	3353-3366	invertebrates	_	_	
21-56	3367-3371	that	_	_	
21-57	3372-3379	consume	_	_	
21-58	3380-3388	microbes	_	_	
21-59	3389-3391	or	_	_	
21-60	3392-3410	microbe-containing	_	_	
21-61	3411-3416	foods	_	_	
21-62	3417-3418	(	_	_	
21-63	3418-3427	including	_	_	
21-64	3428-3433	types	_	_	
21-65	3434-3436	of	_	_	
21-66	3437-3443	filter	_	_	
21-67	3444-3451	feeding	_	_	
21-68	3452-3461	organisms	_	_	
21-69	3461-3462	)	_	_	
21-70	3462-3463	,	_	_	
21-71	3464-3467	low	_	_	
21-72	3468-3470	or	_	_	
21-73	3471-3481	non-oxygen	_	_	
21-74	3482-3492	containing	_	_	
21-75	3493-3500	aquatic	_	_	
21-76	3501-3509	habitats	_	_	
21-77	3510-3511	(	_	_	
21-78	3511-3520	including	_	_	
21-79	3521-3531	freshwater	_	_	
21-80	3531-3532	,	_	_	
21-81	3533-3539	saline	_	_	
21-82	3540-3543	and	_	_	
21-83	3544-3550	marine	_	_	
21-84	3550-3551	)	_	_	
21-85	3551-3552	,	_	_	
21-86	3553-3556	and	_	_	
21-87	3557-3567	especially	_	_	
21-88	3568-3573	at-or	_	_	
21-89	3574-3582	near-low	_	_	
21-90	3583-3589	oxygen	_	_	
21-91	3590-3602	environments	_	_	
21-92	3603-3604	(	_	_	
21-93	3604-3611	regions	_	_	
21-94	3611-3612	)	_	_	
21-95	3613-3615	in	_	_	
21-96	3616-3619	the	_	_	
21-97	3620-3626	oceans	_	_	
21-98	3626-3627	.	_	_	

#Text=The microbial strains would preferably not be obligate anaerobes but be adapted to live in both aerobic and low or anoxic environments.
22-1	3628-3631	The	_	_	
22-2	3632-3641	microbial	_	_	
22-3	3642-3649	strains	_	_	
22-4	3650-3655	would	_	_	
22-5	3656-3666	preferably	_	_	
22-6	3667-3670	not	_	_	
22-7	3671-3673	be	_	_	
22-8	3674-3682	obligate	_	_	
22-9	3683-3692	anaerobes	_	_	
22-10	3693-3696	but	_	_	
22-11	3697-3699	be	_	_	
22-12	3700-3707	adapted	_	_	
22-13	3708-3710	to	_	_	
22-14	3711-3715	live	_	_	
22-15	3716-3718	in	_	_	
22-16	3719-3723	both	_	_	
22-17	3724-3731	aerobic	_	_	
22-18	3732-3735	and	_	_	
22-19	3736-3739	low	_	_	
22-20	3740-3742	or	_	_	
22-21	3743-3749	anoxic	_	_	
22-22	3750-3762	environments	_	_	
22-23	3762-3763	.	_	_	

#Text=Soil environments containing both aerobic and low oxygen or anoxic environments would also excellent environments to find these organisms in and especially in these types of soil in aquatic habitats or temporary aquatic habitats.
#Text=[0156] A particularly preferred microbial strain would be a strain (selected from the group consisting of algae, fungi (including yeast), protozoa or protists) that, during a portion of its life cycle, is capable of consuming whole bacterial cells (bacterivory) by mechanisms such as phagocytosis, phagotrophic or endocytic capability and/or has a stage of its life cycle in which it exists as an amoeboid stage or naked protoplast.
23-1	3764-3768	Soil	_	_	
23-2	3769-3781	environments	_	_	
23-3	3782-3792	containing	_	_	
23-4	3793-3797	both	_	_	
23-5	3798-3805	aerobic	_	_	
23-6	3806-3809	and	_	_	
23-7	3810-3813	low	_	_	
23-8	3814-3820	oxygen	_	_	
23-9	3821-3823	or	_	_	
23-10	3824-3830	anoxic	_	_	
23-11	3831-3843	environments	_	_	
23-12	3844-3849	would	_	_	
23-13	3850-3854	also	_	_	
23-14	3855-3864	excellent	_	_	
23-15	3865-3877	environments	_	_	
23-16	3878-3880	to	_	_	
23-17	3881-3885	find	_	_	
23-18	3886-3891	these	_	_	
23-19	3892-3901	organisms	_	_	
23-20	3902-3904	in	_	_	
23-21	3905-3908	and	_	_	
23-22	3909-3919	especially	_	_	
23-23	3920-3922	in	_	_	
23-24	3923-3928	these	_	_	
23-25	3929-3934	types	_	_	
23-26	3935-3937	of	_	_	
23-27	3938-3942	soil	_	_	
23-28	3943-3945	in	_	_	
23-29	3946-3953	aquatic	_	_	
23-30	3954-3962	habitats	_	_	
23-31	3963-3965	or	_	_	
23-32	3966-3975	temporary	_	_	
23-33	3976-3983	aquatic	_	_	
23-34	3984-3992	habitats	_	_	
23-35	3992-3993	.	_	_	
23-36	3994-3995	[	_	_	
23-37	3995-3999	0156	_	_	
23-38	3999-4000	]	_	_	
23-39	4001-4002	A	_	_	
23-40	4003-4015	particularly	_	_	
23-41	4016-4025	preferred	_	_	
23-42	4026-4035	microbial	_	_	
23-43	4036-4042	strain	_	_	
23-44	4043-4048	would	_	_	
23-45	4049-4051	be	_	_	
23-46	4052-4053	a	_	_	
23-47	4054-4060	strain	_	_	
23-48	4061-4062	(	_	_	
23-49	4062-4070	selected	_	_	
23-50	4071-4075	from	_	_	
23-51	4076-4079	the	_	_	
23-52	4080-4085	group	_	_	
23-53	4086-4096	consisting	_	_	
23-54	4097-4099	of	_	_	
23-55	4100-4105	algae	_	_	
23-56	4105-4106	,	_	_	
23-57	4107-4112	fungi	_	_	
23-58	4113-4114	(	_	_	
23-59	4114-4123	including	_	_	
23-60	4124-4129	yeast	_	_	
23-61	4129-4130	)	_	_	
23-62	4130-4131	,	_	_	
23-63	4132-4140	protozoa	_	_	
23-64	4141-4143	or	_	_	
23-65	4144-4152	protists	_	_	
23-66	4152-4153	)	_	_	
23-67	4154-4158	that	_	_	
23-68	4158-4159	,	_	_	
23-69	4160-4166	during	_	_	
23-70	4167-4168	a	_	_	
23-71	4169-4176	portion	_	_	
23-72	4177-4179	of	_	_	
23-73	4180-4183	its	_	_	
23-74	4184-4188	life	_	_	
23-75	4189-4194	cycle	_	_	
23-76	4194-4195	,	_	_	
23-77	4196-4198	is	_	_	
23-78	4199-4206	capable	_	_	
23-79	4207-4209	of	_	_	
23-80	4210-4219	consuming	_	_	
23-81	4220-4225	whole	_	_	
23-82	4226-4235	bacterial	_	_	
23-83	4236-4241	cells	_	_	
23-84	4242-4243	(	_	_	
23-85	4243-4254	bacterivory	_	_	
23-86	4254-4255	)	_	_	
23-87	4256-4258	by	_	_	
23-88	4259-4269	mechanisms	_	_	
23-89	4270-4274	such	_	_	
23-90	4275-4277	as	_	_	
23-91	4278-4290	phagocytosis	_	_	
23-92	4290-4291	,	_	_	
23-93	4292-4304	phagotrophic	_	_	
23-94	4305-4307	or	_	_	
23-95	4308-4317	endocytic	_	_	
23-96	4318-4328	capability	_	_	
23-97	4329-4332	and	_	_	
23-98	4332-4333	/	_	_	
23-99	4333-4335	or	_	_	
23-100	4336-4339	has	_	_	
23-101	4340-4341	a	_	_	
23-102	4342-4347	stage	_	_	
23-103	4348-4350	of	_	_	
23-104	4351-4354	its	_	_	
23-105	4355-4359	life	_	_	
23-106	4360-4365	cycle	_	_	
23-107	4366-4368	in	_	_	
23-108	4369-4374	which	_	_	
23-109	4375-4377	it	_	_	
23-110	4378-4384	exists	_	_	
23-111	4385-4387	as	_	_	
23-112	4388-4390	an	_	_	
23-113	4391-4399	amoeboid	_	_	
23-114	4400-4405	stage	_	_	
23-115	4406-4408	or	_	_	
23-116	4409-4414	naked	_	_	
23-117	4415-4425	protoplast	_	_	
23-118	4425-4426	.	_	_	

#Text=This method of nutrition would greatly increase the potential for transfer of a bacterial PKS system into a eukaryotic cell if a mistake occurred and the bacterial cell (or its DNA) did not get digested and instead are functionally incorporated into the eukaryotic cell.
24-1	4427-4431	This	_	_	
24-2	4432-4438	method	_	_	
24-3	4439-4441	of	_	_	
24-4	4442-4451	nutrition	_	_	
24-5	4452-4457	would	_	_	
24-6	4458-4465	greatly	_	_	
24-7	4466-4474	increase	_	_	
24-8	4475-4478	the	_	_	
24-9	4479-4488	potential	_	_	
24-10	4489-4492	for	_	_	
24-11	4493-4501	transfer	_	_	
24-12	4502-4504	of	_	_	
24-13	4505-4506	a	_	_	
24-14	4507-4516	bacterial	_	_	
24-15	4517-4520	PKS	_	_	
24-16	4521-4527	system	_	_	
24-17	4528-4532	into	_	_	
24-18	4533-4534	a	_	_	
24-19	4535-4545	eukaryotic	_	_	
24-20	4546-4550	cell	_	_	
24-21	4551-4553	if	_	_	
24-22	4554-4555	a	_	_	
24-23	4556-4563	mistake	_	_	
24-24	4564-4572	occurred	_	_	
24-25	4573-4576	and	_	_	
24-26	4577-4580	the	_	_	
24-27	4581-4590	bacterial	_	_	
24-28	4591-4595	cell	_	_	
24-29	4596-4597	(	_	_	
24-30	4597-4599	or	_	_	
24-31	4600-4603	its	_	_	
24-32	4604-4607	DNA	_	_	
24-33	4607-4608	)	_	_	
24-34	4609-4612	did	_	_	
24-35	4613-4616	not	_	_	
24-36	4617-4620	get	_	_	
24-37	4621-4629	digested	_	_	
24-38	4630-4633	and	_	_	
24-39	4634-4641	instead	_	_	
24-40	4642-4645	are	_	_	
24-41	4646-4658	functionally	_	_	
24-42	4659-4671	incorporated	_	_	
24-43	4672-4676	into	_	_	
24-44	4677-4680	the	_	_	
24-45	4681-4691	eukaryotic	_	_	
24-46	4692-4696	cell	_	_	
24-47	4696-4697	.	_	_	
